These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12368134)

  • 41. Commentary: randomized controlled trials.
    Brennan MF
    Surg Oncol Clin N Am; 2010 Jan; 19(1):xix-xx. PubMed ID: 19914555
    [No Abstract]   [Full Text] [Related]  

  • 42. Improving trial design in cancer anesthesia (onco-anesthesia) research.
    Hiller JG; Myles PS; Ramsay RG; Riedel BJ
    Can J Anaesth; 2017 Aug; 64(8):872-873. PubMed ID: 28361389
    [No Abstract]   [Full Text] [Related]  

  • 43. Is this the end of research as we know it?
    Proctor S
    BMJ; 1997 Aug; 315(7105):388. PubMed ID: 9277600
    [No Abstract]   [Full Text] [Related]  

  • 44. Family observation of antituberculosis treatment.
    Mohapatra PR; Janmeja AK
    Lancet; 2006 Jun; 367(9528):2055; author reply 2055-6. PubMed ID: 16798378
    [No Abstract]   [Full Text] [Related]  

  • 45. Commentary on the use of run-in periods in clinical trials.
    Franciosa JA
    Am J Cardiol; 1999 Mar; 83(6):942-4, A9. PubMed ID: 10190414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CONSORT.
    Black N
    Lancet; 1996 Sep; 348(9029):756-7. PubMed ID: 8806314
    [No Abstract]   [Full Text] [Related]  

  • 47. [Power, you can never have enough of it].
    Groenwold RHH; van Smeden M; Dekkers OM
    Ned Tijdschr Geneeskd; 2018; 162():D2163. PubMed ID: 29600924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Methodology of therapeutic trials in cancerology].
    Hayat MM
    Bord Med; 1972 Dec; 5(20):2747-55. PubMed ID: 4573744
    [No Abstract]   [Full Text] [Related]  

  • 49. Do we need randomised trials for rare cancers?
    Prasad V; Oseran A
    Eur J Cancer; 2015 Jul; 51(11):1355-7. PubMed ID: 25963018
    [No Abstract]   [Full Text] [Related]  

  • 50. Randomized trials: what's the problem?
    Cavalli F
    Ann Oncol; 1992 Feb; 3(2):96. PubMed ID: 1307854
    [No Abstract]   [Full Text] [Related]  

  • 51. [The clinical relevance of effect sizes].
    Windeler J; Thomas S
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(3):244-8; discussion 249. PubMed ID: 20608254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The recruitment of patients into clinical trials.
    Tannock IF
    Br J Cancer; 1995 Jun; 71(6):1134-5. PubMed ID: 7779700
    [No Abstract]   [Full Text] [Related]  

  • 53. Can results from clinical trials be generalized?
    Holmberg L; Baum M
    Nat Med; 1995 Aug; 1(8):734-6. PubMed ID: 7585167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The case for randomized trials in cancer treatment: new is not always better.
    Grann A; Grann VR
    JAMA; 2005 Feb; 293(8):1001-3. PubMed ID: 15728172
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cancerology in modern medicine].
    Tagnon HJ
    Brux Med; 1967 Jun; 47(26):691-7. PubMed ID: 5607122
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cyclotherapy; practical use and indications in cancerology].
    HERVE A
    Rev Med Liege; 1952 Oct; 7(20):675-84. PubMed ID: 13027884
    [No Abstract]   [Full Text] [Related]  

  • 57. Methods of assessing medical treatments.
    Fontaine A; Durieux P
    BMJ; 1994 Sep; 309(6956):741. PubMed ID: 7950540
    [No Abstract]   [Full Text] [Related]  

  • 58. [Current data on cancerology 1966].
    Collina G
    Minerva Med; 1967 Aug; 58(67):2891-909. PubMed ID: 4863072
    [No Abstract]   [Full Text] [Related]  

  • 59. A summary of cancerology; treatment.
    RIORDAN DJ
    J Med Assoc Eire; 1947 Mar; 20(117):238-40. PubMed ID: 20288281
    [No Abstract]   [Full Text] [Related]  

  • 60. [Derived from hyperite in cancerology].
    HERVE A
    Scalpel (Brux); 1948 Sep; 101(36):862. PubMed ID: 18885133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.